Suzanne Wallis
Family · Clermont, FLNPI 1346603925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $688, 2.8 times the $245 reported in 2021.
Across 107 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$422
- Vanda Pharmaceuticals Inc.$354
- AbbVie$318
- Corium, LLC$154
- Pfizer$132
- Lilly USA, LLC$107
- plus $856 from 22 others
What the payments were for
- Food & beverage$2,343100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 7 | $422 |
| Vanda Pharmaceuticals Inc. | 15 | $354 |
| AbbVie | 18 | $318 |
| Corium, LLC | 10 | $154 |
| Pfizer | 7 | $132 |
| Lilly USA, LLC | 6 | $107 |
| Sanofi Pasteur Inc. | 5 | $97 |
| Tris Pharma Inc | 5 | $80 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Phadia US Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 4 | $60 |
| Merck | 2 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Novo Nordisk | 2 | $43 |
| Gilead | 2 | $31 |
| Abbott | 1 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| UCB, Inc. | 1 | $29 |
| Qiagen, LLC | 1 | $26 |
| Indivior Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| GSK | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$357
How this compares
$2,343 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Other family in Clermont
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.